BERLIN (Reuters) – Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move its research to the United States, prompting German politicians to insist no country should have a monopoly on any future vaccine.

Germany’s Health Ministry confirmed a report in newspaper Welt am Sonntag, which said President Donald Trump had offered funds to lure the company CureVac to the United States, and the German government was making counter-offers to tempt it to stay.

“The German government is very interested in ensuring that vaccines and active substances against the new coronavirus are also developed in Germany and Europe,” the newspaper quoted a Health Ministry official as saying. “In this regard, the government is in intensive exchange with the company CureVac.”

Contacted by Reuters, a spokeswoman for the German Health Ministry said: “We confirm the report in the Welt am Sonntag.”

Welt am Sonntag quoted an unidentified German government source as saying Trump was trying to secure the scientists’ work exclusively, and would do anything to get a vaccine for the United States, “but only for the United States.”

There was no comment immediately available from the U.S. embassy in Berlin when contacted by Reuters on Sunday over the report, and nobody was available to comment at CureVac. Welt am Sonntag said CureVac declined to comment.

Florian von der Muelbe, CureVac’s chief production officer and co-founder, told Reuters last week the company had started with a multitude of coronavirus vaccine candidates and was now selecting the two best to go into clinical trials.

The privately-held company based in Tuebingen, Germany hopes to have an experimental vaccine ready by June or July to then seek the go-ahead from regulators for testing on humans.

On its website, CureVac said CEO Daniel Menichella early this month met Trump, Vice President Mike Pence, members of the White House Coronavirus Task Force and senior representatives of pharmaceutical and biotech companies to discuss a vaccine.

Karl Lauterbach, a professor of health economics and epidemiology who is also a senior lawmaker with the Social Democrats, junior partners in Chancellor Angela Merkel’s coalition, tweeted in reaction to the Welt am Sonntag report: “The exclusive sale of a possible vaccine to the USA must be prevented by all means. Capitalism has limits.”

CureVac in 2015 and 2018 secured financial backing for vaccine development projects from its investor the Bill & Melinda Gates Foundation, working on shots to prevent malaria and influenza.

In the field of so-called mRNA therapeutics, CureVac competes with U.S. biotech firm Moderna and German rival BioNTech, which Pfizer (PFE.N) has identified as a potential collaboration partner.

Drugs based on mRNA provide a type of genetic blueprint that can be injected into the body to instruct cells to produce the desired therapeutic proteins. That contrasts with the conventional approach of making these proteins in labs and bio-reactors.

In the case of vaccines, the mRNA prompts body cells to produce so-called antigens, the tell-tale molecules on the surface of viruses, that spur the immune system into action.

Companies working on other coronavirus-vaccine approaches include Johnson & Johnson (JNJ.N) and INOVIO Pharmaceuticals, Inc. (INO.O).

Additional reporting by Ludwig Burger; Editing by Alexandra Hudson

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Charlie Skelton The diversity crisis at the world’s most influential think tank

When Mark Carney took over at the Bank of England in 2013 he was the first foreign governor in its history. The Financial Times described him as “the new broom”. The Independent dubbed him a “dark horse”. Yet Carney saw…

Germany to hold crisis talks with Lufthansa investor over bailout: source

FRANKFURT (Reuters) – Lufthansa’s (LHAG.DE) biggest shareholder, billionaire Heinz Hermann Thiele, will meet Germany’s economics minister for talks on Monday about a 9 billion euro ($10.1 billion) bailout for the airline, a source close to the matter told Reuters. Thiele…

Trump gives governors options on how to reopen the economy

WASHINGTON — President Donald Trump has given governors a road map for recovering from the economic pain of the coronavirus pandemic, laying out “a phased and deliberate approach” to restoring normal activity in places that have strong testing and are…

U.S. SEC orders Wells Fargo pay $35 million for recommendations of high-risk products

WASHINGTON (Reuters) – The U.S. Securities and Exchange Commission said on Thursday it had ordered Wells Fargo & Co (WFC.N) to pay $35 million to settle charges it failed to adequately supervise investment advisers who were recommending high-risk products. Wells…